Skip to content

Isokinetic Strength and Anaerobic Capacity

The Effect of Isokinetic Strength on Anaerobic Capacity in Recreationally Active Young Adult Males

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07376551
Acronym
ISAC
Enrollment
80
Registered
2026-01-29
Start date
2026-01-05
Completion date
2026-03-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult, Physical Condition

Keywords

Physical Fitness, Exercise Test, Acute Exercise

Brief summary

This study aims to investigate differences in isokinetic knee extensor and flexor strength parameters among recreationally active young adult males classified into low, moderate, and high anaerobic power groups based on relative peak power (W/kg) obtained from the Wingate Anaerobic Test. Eighty male participants aged 22-30 years, engaging in regular physical activity, will undergo body composition analysis, isokinetic strength testing at 60°/s, and a 30-second Wingate test performed on separate days. Participants will be grouped according to median-based anaerobic power classification to allow meaningful group comparisons. Group differences in peak torque and total work will be analyzed using ANOVA or non-parametric equivalents, and relationships between Wingate parameters and isokinetic strength will be examined using correlation analyses. The findings are expected to provide novel insights into the relationship between anaerobic power classification and lower-extremity muscle strength profiles, contributing to performance profiling and training planning in recreationally active populations.

Detailed description

This study will investigate the relationship between anaerobic power classification and isokinetic lower-extremity muscle strength in recreationally active young adult males. Participants will be classified into three anaerobic power groups (low, moderate, and high) based on relative peak power (W/kg) obtained from the Wingate Anaerobic Test. This classification approach is intended to move beyond single-variable correlation analyses commonly reported in the literature and to enable meaningful group-based comparisons of muscle strength profiles. A total of 80 male participants aged 22-30 years who engage in regular physical activity at least twice per week will be recruited. Individuals with a history of serious orthopedic injury within the past six months, cardiovascular or respiratory disease, or regular medication use will be excluded. Body composition parameters will be assessed using bioelectrical impedance analysis prior to performance testing. Isokinetic knee extensor and flexor strength of the dominant leg will be evaluated using concentric contractions at an angular velocity of 60°/s. Peak torque and total work values will be recorded as primary isokinetic strength outcomes. Anaerobic performance will be assessed on a separate day using a 30-second Wingate Anaerobic Test performed on a cycle ergometer, during which participants will be verbally encouraged to exert maximal effort throughout the test. Relative peak power, mean power, and fatigue index values will be obtained. Participants will be grouped according to median-based classification of relative peak power values to facilitate comparison among anaerobic power levels in a sample of limited size. Differences in isokinetic strength parameters between groups will be analyzed using one-way analysis of variance or non-parametric equivalents when appropriate. Associations between Wingate-derived anaerobic parameters and isokinetic strength measures will also be examined using correlation analyses. The results of this study are expected to clarify whether individuals with higher anaerobic power levels demonstrate superior isokinetic knee extensor and flexor strength profiles. The findings may contribute to a better understanding of the interaction between anaerobic performance capacity and lower-extremity muscle strength, with potential implications for performance profiling, training program design, and exercise-based rehabilitation strategies in recreationally active populations.

Interventions

None listed

Sponsors

Uludag University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
20 Years to 32 Years
Healthy volunteers
Yes

Inclusion criteria

* Male participants aged between 20 and 30 years * Moderately physically active individuals, as defined by the International Physical Activity Questionnaire (IPAQ) * Apparently healthy, with no known neurological, vestibular, or musculoskeletal disorders affecting balance * Ability to stand independently and complete balance assessments * Willingness to participate and provide written informed consent

Exclusion criteria

* History of lower-limb, spine, or pelvic injury or surgery within the past 6 months * Presence of acute or chronic pain affecting posture or balance * Diagnosed neurological, vestibular, or balance disorders * Use of medications or substances that may affect neuromuscular function or postural control * Participation in another clinical or observational study within the past 3 months

Design outcomes

Primary

MeasureTime frameDescription
Isokinetic knee extensor and flexor peak torque (Nm) at 60°/sday 1 (Assessed during a single laboratory testing session.)Peak torque values of the knee extensor and flexor muscles will be assessed using isokinetic dynamometry during concentric contractions at an angular velocity of 60°/s. Measurements will be obtained from the dominant leg following a standardized warm-up protocol. Peak torque (Nm) will be used as the primary indicator of maximal dynamic muscle strength.

Secondary

MeasureTime frameDescription
Wingate-derived anaerobic performance parametersday 1 (Assessed during a single laboratory testing session.)Anaerobic performance will be assessed using the 30-second Wingate Anaerobic Test performed on a cycle ergometer. Relative peak power (W/kg) will be used.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026